Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region
- PMID: 1697856
Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region
Abstract
Previous studies revealed that antisense oligodeoxynucleotides to specific regions of the human immunodeficiency virus-1 (HIV-1) are potent inhibitors of replication of HIV-1 in vitro (Zamecnik, P. C., Goodchild, J., Taguchi, Y., and Sarin, P. S. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 4143-4146). We now report that antisense RNA, synthesized in vitro using T7 and SP6 RNA polymerase, displayed an anti-HIV-1 effect in the HTLV-IIIB/H9 system in vitro. Treatment of HIV-1-infected H9 cells with viral env region antisense RNA encapsulated in liposomes targeted by antibodies specific for the T cell receptor molecule CD3 almost completely inhibited HIV-1 production. The viral env segment covered a part of exon II of HIV-1 tat gene. No anti-HIV activity could be detected with similarly targeted liposome-encapsulated sense env RNA or with pol RNA synthesized in either the sense or antisense orientations, or with env region antisense RNA free in solution, or encapsulated in liposomes in the absence of the targeting antibody. A semiquantitative evaluation revealed that 4000-7000 RNA molecules became cell-bound in targeted liposomes; the half-life of the intracellularly present hybridizable antisense env RNA was approximately 12 h. Western blots showed that antisense env RNA suppressed tat gene expression by approximately 90% and gp160 production by 100%. These data were confirmed by immunoprecipitation studies. Northern blots (using an env probe) demonstrated the existence of all major HIV RNA species (9.3-, 4.3-, and 2.0-kb mRNA) in HIV-infected cells treated with antisense env RNA although at a reduced level. We conclude that the antisense env RNA inhibited viral protein production at the translational level.
Similar articles
-
Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.J Virol. 1998 Mar;72(3):1894-901. doi: 10.1128/JVI.72.3.1894-1901.1998. J Virol. 1998. PMID: 9499041 Free PMC article.
-
A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.Front Biosci. 2002 Feb 1;7:a15-28. doi: 10.2741/ding. Front Biosci. 2002. PMID: 11815282
-
Expression of human immunodeficiency virus 1 (HIV-1) envelope gene products transcribed from a heterologous promoter. Kinetics of HIV-1 envelope processing in transfected cells.J Biol Chem. 1990 Nov 5;265(31):19151-7. J Biol Chem. 1990. PMID: 2229068
-
HIV-1 replication.Somat Cell Mol Genet. 2001 Nov;26(1-6):13-33. doi: 10.1023/a:1021070512287. Somat Cell Mol Genet. 2001. PMID: 12465460 Review.
-
Retroviral Antisense Transcripts and Genes: 33 Years after First Predicted, a Silent Retroviral Revolution?Viruses. 2021 Nov 4;13(11):2221. doi: 10.3390/v13112221. Viruses. 2021. PMID: 34835027 Free PMC article. Review.
Cited by
-
Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.J Virol. 1998 Mar;72(3):1894-901. doi: 10.1128/JVI.72.3.1894-1901.1998. J Virol. 1998. PMID: 9499041 Free PMC article.
-
An anti-lymphocytic choriomeningitis virus ribozyme expressed in tissue culture cells diminishes viral RNA levels and leads to a reduction in infectious virus yield.J Virol. 1993 Apr;67(4):1840-7. doi: 10.1128/JVI.67.4.1840-1847.1993. J Virol. 1993. PMID: 8445712 Free PMC article.
-
Thermodynamics and dynamics of the formation of spherical lipid vesicles.J Biol Phys. 2009 Aug;35(3):297-308. doi: 10.1007/s10867-009-9169-5. Epub 2009 Jun 25. J Biol Phys. 2009. PMID: 19669580 Free PMC article.
-
Ribozymes: biology, biochemistry, and implications for clinical medicine.J Mol Med (Berl). 1995 Feb;73(2):65-71. doi: 10.1007/BF00270579. J Mol Med (Berl). 1995. PMID: 7627631 Review.
-
A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.J Cancer Res Clin Oncol. 1997;123(2):91-9. doi: 10.1007/BF01269886. J Cancer Res Clin Oncol. 1997. PMID: 9030247 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources